BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 14, 2000
View Archived Issues
Medarex and Oxford GlycoSciences to codevelop human antibody therapeutics
Read More
GlycoDesign and Seikagaku expand drug development agreement
Read More
Safety study of anti-hepatitis C ribozyme compound completed
Read More
Oxygent reduces the need for donor blood in phase III trial
Read More
Synthetic antioxidant compounds extend the life span of C. elegans
Read More
St. John's wort extract and imipramine equally efficacious in treating depression
Read More
Telomerase immunization induces antitumor response
Read More
Nebulized heparin reduces airways inflammation, improves spirometric parameters in asthma
Read More
German scientists study antisense oligonucleotides as a novel, noninvasive approach to asthma
Read More
Renal I/R injury prevented by VAS-971 therapy in canine model
Read More
HuM291 appears to induce transplant tolerance via apoptosis of activated T-cells
Read More
New leads in the search for next-generation microtubule-directed taxoids
Read More
Clinical candidate for allergic cutaneous disorders selected at Japan Energy
Read More
Cystistat approved for expanded indications in Europe
Read More
Analgesic activity demonstrated for Abbott's novel nAChR ligands
Read More
Vernalis patents new NMDA antagonists with favorable cortical to cerebellar ratio
Read More
Recent patent covers heterocyclic 5-HT reuptake inhibitors discovered at BMS
Read More
Potential new anticonvulsants presented by Boehringer Ingelheim
Read More
Screening collaboration between CDD and CST to identify novel kinase inhibitors
Read More
Clinical trials with polymer platinate AP-5280 to begin
Read More
Inhibitors of nitric oxide synthase in early development at Pharmacia
Read More
Exclusive access to technology for potential cancer vaccine granted to Viragen
Read More
Nanomolar binding affinity for A3 receptor demonstrated for certain new thiazolopyrimidines
Read More
British Biotech designs new LTA4 hydrolase inhibitors
Read More
Prodrugs of known BK(Ca) channel opener reported by BMS
Read More